Patients with new-onset low back pain who initially consulted a chiropractor or physical therapist vs a primary care physician were found to have reduced risk for long-term opioid use.
Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.
The drugs most frequently involved in drug overdose deaths in 2017 varied regionally in the United States.
Clinicians working with people with opioid use disorder can help to decrease the stigma and bias against these individuals.
Odds of short- or long-term opioid use higher for initial visits with physicians for low back pain.
Patients on long-term opioid treatment for chronic pain reported experiencing negative physical side effects, emotional distress, and degraded relationships with their primary care provider.
The Canadian Research Initiative in Substance Misuse National Injectable Opioid Agonist Treatment Steering Committee has released a new guideline on the use of injectable opioid agonist treatment for opioid use disorder.
Restrictions on prescribing methadone, buprenorphine, and naloxone pose a significant barrier to effective treatment of patients with opioid use disorder.
There are a number of challenges associated with the use of cannabidiol and hemp oils in pain management.
The majority of existing clinical guidelines and consensus statements on pain management at the end of life in the intensive care unit agree on a set of recommendations that include the use of high doses of opioid.
